These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 32169805)

  • 1. Targeting Ephrin Receptor Tyrosine Kinase A2 with a Selective Aptamer for Glioblastoma Stem Cells.
    Affinito A; Quintavalle C; Esposito CL; Roscigno G; Giordano C; Nuzzo S; Ricci-Vitiani L; Scognamiglio I; Minic Z; Pallini R; Berezovski MV; de Francisis V; Condorelli G
    Mol Ther Nucleic Acids; 2020 Jun; 20():176-185. PubMed ID: 32169805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Discovery of RNA Aptamers that Selectively Bind Glioblastoma Stem Cells.
    Affinito A; Quintavalle C; Esposito CL; Roscigno G; Vilardo C; Nuzzo S; Ricci-Vitiani L; De Luca G; Pallini R; Kichkailo AS; Lapin IN; de Franciscis V; Condorelli G
    Mol Ther Nucleic Acids; 2019 Dec; 18():99-109. PubMed ID: 31541799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cotargeting Ephrin Receptor Tyrosine Kinases A2 and A3 in Cancer Stem Cells Reduces Growth of Recurrent Glioblastoma.
    Qazi MA; Vora P; Venugopal C; Adams J; Singh M; Hu A; Gorelik M; Subapanditha MK; Savage N; Yang J; Chokshi C; London M; Gont A; Bobrowski D; Grinshtein N; Brown KR; Murty NK; Nilvebrant J; Kaplan D; Moffat J; Sidhu S; Singh SK
    Cancer Res; 2018 Sep; 78(17):5023-5037. PubMed ID: 29945963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engagement of cellular prion protein with the co-chaperone Hsp70/90 organizing protein regulates the proliferation of glioblastoma stem-like cells.
    Iglesia RP; Prado MB; Cruz L; Martins VR; Santos TG; Lopes MH
    Stem Cell Res Ther; 2017 Apr; 8(1):76. PubMed ID: 28412969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of transforming growth factor-β signaling enhances oncolytic herpes simplex virus efficacy in patient-derived recurrent glioblastoma models.
    Esaki S; Nigim F; Moon E; Luk S; Kiyokawa J; Curry W; Cahill DP; Chi AS; Iafrate AJ; Martuza RL; Rabkin SD; Wakimoto H
    Int J Cancer; 2017 Dec; 141(11):2348-2358. PubMed ID: 28801914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SOX transcription factors and glioma stem cells: Choosing between stemness and differentiation.
    Stevanovic M; Kovacevic-Grujicic N; Mojsin M; Milivojevic M; Drakulic D
    World J Stem Cells; 2021 Oct; 13(10):1417-1445. PubMed ID: 34786152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of RNA and DNA Aptamers in Glioblastoma Diagnosis and Therapy: A Systematic Review of the Literature.
    Nuzzo S; Brancato V; Affinito A; Salvatore M; Cavaliere C; Condorelli G
    Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32764266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The anti-vascular endothelial growth factor receptor-1 monoclonal antibody D16F7 inhibits invasiveness of human glioblastoma and glioblastoma stem cells.
    Atzori MG; Tentori L; Ruffini F; Ceci C; Lisi L; Bonanno E; Scimeca M; Eskilsson E; Daubon T; Miletic H; Ricci Vitiani L; Pallini R; Navarra P; Bjerkvig R; D'Atri S; Lacal PM; Graziani G
    J Exp Clin Cancer Res; 2017 Aug; 36(1):106. PubMed ID: 28797294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Prognostic Model and Biomarkers for Cancer Stem Cell Characteristics in Glioblastoma by Network Analysis of Multi-Omics Data and Stemness Indices.
    Du J; Yan X; Mi S; Li Y; Ji H; Hou K; Ma S; Ba Y; Zhou P; Chen L; Xie R; Hu S
    Front Cell Dev Biol; 2020; 8():558961. PubMed ID: 33195193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual Role of Integrin Alpha-6 in Glioblastoma: Supporting Stemness in Proneural Stem-Like Cells While Inducing Radioresistance in Mesenchymal Stem-Like Cells.
    Stanzani E; Pedrosa L; Bourmeau G; Anezo O; Noguera-Castells A; Esteve-Codina A; Passoni L; Matteoli M; de la Iglesia N; Seano G; Martínez-Soler F; Tortosa A
    Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34205341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Human Glioblastoma with a Live Attenuated Zika Virus Vaccine Candidate.
    Chen Q; Wu J; Ye Q; Ma F; Zhu Q; Wu Y; Shan C; Xie X; Li D; Zhan X; Li C; Li XF; Qin X; Zhao T; Wu H; Shi PY; Man J; Qin CF
    mBio; 2018 Sep; 9(5):. PubMed ID: 30228241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging targets for glioblastoma stem cell therapy.
    Safa AR; Saadatzadeh MR; Cohen-Gadol AA; Pollok KE; Bijangi-Vishehsaraei K
    J Biomed Res; 2016 Jan; 30(1):19-31. PubMed ID: 26616589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A curcumin derivative hydrazinobenzoylcurcumin suppresses stem-like features of glioblastoma cells by targeting Ca
    Shin HJ; Lee S; Jung HJ
    J Cell Biochem; 2019 Apr; 120(4):6741-6752. PubMed ID: 30390339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aptamer targeting EGFRvIII mutant hampers its constitutive autophosphorylation and affects migration, invasion and proliferation of glioblastoma cells.
    Camorani S; Crescenzi E; Colecchia D; Carpentieri A; Amoresano A; Fedele M; Chiariello M; Cerchia L
    Oncotarget; 2015 Nov; 6(35):37570-87. PubMed ID: 26461476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of Nucleic Acid Aptamers Capable of Specifically Targeting Glioma Stem Cells via Cell-SELEX.
    Wu Q; Lin N; Tian T; Zhu Z; Wu L; Wang H; Wang D; Kang D; Tian R; Yang C
    Anal Chem; 2019 Jul; 91(13):8070-8077. PubMed ID: 31179688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Small Molecule Ephrin Receptor Inhibitor, GLPG1790, Reduces Renewal Capabilities of Cancer Stem Cells, Showing Anti-Tumour Efficacy on Preclinical Glioblastoma Models.
    Gravina GL; Mancini A; Colapietro A; Delle Monache S; Sferra R; Vitale F; Cristiano L; Martellucci S; Marampon F; Mattei V; Beirinckx F; Pujuguet P; Saniere L; Lorenzon G; van der Aar E; Festuccia C
    Cancers (Basel); 2019 Mar; 11(3):. PubMed ID: 30871240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyethylenimine-Spherical Nucleic Acid Nanoparticles against Gli1 Reduce the Chemoresistance and Stemness of Glioblastoma Cells.
    Melamed JR; Ioele SA; Hannum AJ; Ullman VM; Day ES
    Mol Pharm; 2018 Nov; 15(11):5135-5145. PubMed ID: 30260647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential Therapeutic Effects of the Neural Stem Cell-Targeting Antibody Nilo1 in Patient-Derived Glioblastoma Stem Cells.
    Rackov G; Iegiani G; Uribe D; Quezada C; Belda-Iniesta C; Escobedo-Lucea C; Silva A; Puig P; González-Rumayor V; Ayuso-Sacido Á
    Front Oncol; 2020; 10():1665. PubMed ID: 32974206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glioblastoma cancer stem cells: role of the microenvironment and therapeutic targeting.
    Persano L; Rampazzo E; Basso G; Viola G
    Biochem Pharmacol; 2013 Mar; 85(5):612-622. PubMed ID: 23063412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stemness Marker Detection in the Periphery of Glioblastoma and Ability of Glioblastoma to Generate Glioma Stem Cells: Clinical Correlations.
    Raysi Dehcordi S; Ricci A; Di Vitantonio H; De Paulis D; Luzzi S; Palumbo P; Cinque B; Tempesta D; Coletti G; Cipolloni G; Cifone MG; Galzio R
    World Neurosurg; 2017 Sep; 105():895-905. PubMed ID: 28559081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.